<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01185912</url>
  </required_header>
  <id_info>
    <org_study_id>1/2006</org_study_id>
    <nct_id>NCT01185912</nct_id>
  </id_info>
  <brief_title>Cardiomyocyte Apoptosis Following Antegrade and Retrograde Cardioplegia</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Finnish Foundation for Cardiovascular Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrograde cardioplegia during heart surgery is associated with inadequate myocardial
      protection. In experimental animal study retrograde cardioplegia induces more cardiomyocyte
      apoptosis when compared to antegrade cardioplegia. 20 volunteer patients under going elective
      aortic valve surgery will be divided in to two groups: 10 patients receiving only antegrade
      cardioplegia and 10 patients receiving only retrograde cardioplegia. Pre- and
      post-operatively cardiac MRI and cardiac ultrasound will be performed. During the surgery
      ventricular muscle samples will be taken in order to assess cardiomyocyte apoptosis. Aims of
      the study: 1. whether the cardiomyocyte apoptosis is significantly more induced after
      retrograde cardioplegia than antegrade cardioplegia, 2. whether the amount of apoptotic
      cardiomyocytes correlates to conventional markers of myocardial injury after cardiac surgery,
      3. whether the extent of irreversible myocardial damage by apoptosis correlates to
      post-ischemic contractile dysfunction after cardiac surgery, as measured with
      echocardiography, 4. whether the amount of cardiomyocyte apoptosis correlates to long term
      outcome and cardiac function as measured with MRI.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">20</enrollment>
  <condition>Cardiomyocyte Apoptosis</condition>
  <arm_group>
    <arm_group_label>Cardiomyocyte apoptosis</arm_group_label>
    <description>Elective aortic valve replacement patience</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ventricle muscle tissue samples</intervention_name>
    <arm_group_label>Cardiomyocyte apoptosis</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Transmyocardial needle biopsies
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        20 patients (male and female) undergoing elective aortic valve replacement surgery due to
        aortic valve stenosis or combined aortic valve disease in Turku University Hospital,
        Department of Surgery.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aortic valve stenosis or combined aortic valve disease

        Exclusion Criteria:

          -  angiographically verified hemodynamically significant coronary artery disease impaired
             left ventricular function (left ventricular ejection fraction &lt;50%) surgery including
             additional procedures other than aortic valve replacement cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Turku University Hospital, Department of Surgery</name>
      <address>
        <city>Turku</city>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2010</study_first_submitted>
  <study_first_submitted_qc>August 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 20, 2010</study_first_posted>
  <last_update_submitted>May 19, 2015</last_update_submitted>
  <last_update_submitted_qc>May 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Turku University Hospital</investigator_affiliation>
    <investigator_full_name>Markus Malmberg</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Cardiac MRI</keyword>
  <keyword>Cardiac ultrasound</keyword>
  <keyword>Cardiac surgery</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

